Royalty Pharma PLC RPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
28.16UNCH (UNCH)
Volume
51,140
Close
28.16quote price arrow up+0.27 (+0.97%)
Volume
1,724,554
52 week range
25.92 - 36.48
Loading...
  • Open27.85
  • Day High28.19
  • Day Low27.69
  • Prev Close27.89
  • 52 Week High36.48
  • 52 Week High Date04/21/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23

Key Stats

  • Market Cap16.824B
  • Shares Out597.43M
  • 10 Day Average Volume2.65M
  • Dividend0.84
  • Dividend Yield2.98%
  • Beta0.47
  • YTD % Change0.25

KEY STATS

  • Open27.85
  • Day High28.19
  • Day Low27.69
  • Prev Close27.89
  • 52 Week High36.48
  • 52 Week High Date04/21/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23
  • Market Cap16.824B
  • Shares Out597.43M
  • 10 Day Average Volume2.65M
  • Dividend0.84
  • Dividend Yield2.98%
  • Beta0.47
  • YTD % Change0.25

RATIOS/PROFITABILITY

  • EPS (TTM)2.53
  • P/E (TTM)11.12
  • Fwd P/E (NTM)7.22
  • EBITDA (TTM)1.492B
  • ROE (TTM)18.67%
  • Revenue (TTM)2.355B
  • Gross Margin (TTM)-
  • Net Margin (TTM)72.20%
  • Debt To Equity (MRQ)94.01%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date05/16/2024
  • Div Amount0.21
  • Split Date-
  • Split Factor-

Latest On Royalty Pharma PLC

 

Profile

MORE
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya...
Pablo Legorreta
Chairman of the Board, Chief Executive Officer
Christopher Hite
Vice Chairman, Executive Vice President
Terrance Coyne
Chief Financial Officer, Executive Vice President
George Lloyd
Executive Vice President - Investments and Chief Legal Officer
Marshall Urist M.D., Ph.D.
Executive Vice President - Research and Investments
Address
110 East 59th Street
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
UTHR
United Therapeutics Corp
237.93+1.00+0.42%
BMRN
Biomarin Pharmaceutical Inc
88.63-1.44-1.60%
CTLT
Catalent Inc
55.48-0.32-0.57%
IONS
Ionis Pharmaceuticals Inc
40.68-0.13-0.32%
ELAN
Elanco Animal Health Inc
12.95-0.62-4.57%